Omeza® is an ocean biotechnology company accelerating healing for chronic, hard-to-heal wounds. Powered by marine-derived fish peptides, our products reduce inflammation, jumpstart tissue growth, and restore healthy skin.
Our Mission
To make advanced wound care accessible, sustainable and cost-effective.
Our Goal
To become the new standard of care for skin ulcers and chronic wounds.
Our Approach
Simple, safe, sustainable and clinically-proven.
THE SOLUTION
Introducing OCM™
OCM™ wound matrix is a novel, proprietary technology focused on comprehensive wound healing. It is the only FDA-cleared product that is proven to support all phases of wound healing.
OCM™ wound matrix provides pharmaceutical grade time-released elements that migrate into the tunnels and crevices of the wound bed to support each stage of wound healing.
- DECREASE INFLAMMATION
- INCREASE PROLIFERATION
- SUPPORT REMODELING
- REDUCE BIOFILM IMPACT
Formulated and Manufactured in the USA.
PRESS RELEASES
Our Latest Press Releases
ViaCLYR™, Microlyte® PainGuard® with Lidocaine, and Omeza® additions ensure Veterans receive the most innovative wound care treatments available. GAITHERSBURG, MD, UNITED STATES, November 11, 2026 /EINPresswire.com/ — As Spartan Medical® celebrates its 19th Veterans Day, our principal mission through the years has been to serve veterans, and the Providers that care for them. One major […]
SARASOTA, Fla., Sept. 21, 2026 /PRNewswire-PRWeb/ — OMEZA Holdings Inc. (OMEZA) is pleased to announce that it has signed an exclusive partnership agreement with Hikma Pharmaceuticals (Hikma), the largest pharmaceutical company in MENA by sales (1) opening access to OCM™ (OMEZA Complete Matrix) for advanced wound care patients in select Middle East and North Africa […]
ABOUT OMEZA
Who Are We?
Omeza® is an ocean biotechnology company that develops marine-based products containing cold-water fish peptides and other pharmaceutical-grade components designed to reduce inflammation, increase tissue proliferation, and support skin remodeling in adults with a range of chronic, hard-to-heal wounds.
Founded in 2014, the company is headquartered in Sarasota, Florida, and has research, manufacturing, and analytical facilities located throughout Florida.
UNMET NEED
Chronic Wounds are a Growing Burden
for The US Health System.
10 million patients in the US suffer from chronic wounds
2 major indications, Diabetic Foot Ulcers (DFUs) and Venous Leg Ulcers (VLUs) represent 2.5M+ new patients each year.
Standard of care remains suboptimal
Despite decades of innovation, there is an up to 30% failure rate after months of treatment and costs are now over $100,000 per patient for many.
MECHANISM OF ACTION
How Does OCM™ Work?
A first of its kind drug-device
OCM™ provides immediate structural coverage
OCM™ is a first-in-class formulation with multi-modal mechanisms of action that treats most types of chronic wounds.
OCM™ is created through a proprietary process
OCM™ is a malleable solid to fit any wound shape
It is an amorphous solid that covers the wound bed (including tunnels), forming a malleable sheet that provides support for comprehensive healing.
Created using pharmaceutical-grade components
Formulated under strict cleanroom conditions
OCM™ is a water-free, oil-based matrix comprised of hydrolyzed cold-water fish peptides, derived omega fatty acids, nutrients and plant-derived oils and waxes.
OUR COMMITMENT TO SUSTAINABILITY
Our Natural Ingredients Are Sustainably Sourced
Our product formulation combines these cold-water fish peptides with pharmaceutical-grade, plant-derived lipids and waxes. Key marine and natural ingredients include:
Hydrolyzed Fish Collagen
Sourced from North Atlantic white fish, it acts as a structural scaffold that allows new skin and tissue to regenerate.
Cod Liver Oil
Provides a rich source of vitamins (A, C, D, E) and serves as an anhydrous skin protectant to maintain a moist healing environment.
Omega Fatty Acids
Includes naturally occurring Omega 3, 6, and 9 to help decrease inflammation, manage bacterial contamination (like biofilms), and support tissue remodeling.
OUR MISSION
Restoring Skin Integrity
Wound Management & Prevention (WMP) Journal selected Omeza for a ‘Top Innovation in Wound Care 2022’ Award for the Omeza products bundle. At the core of this award-winning system is the Omeza® Complete Matrix Rx, engineered to decrease inflammation, increase proliferation, support remodeling, and reduce biofilm impact at any site of care.
View More
Connect with Our Experts
Direct your inquiry to the appropriate Omeza division, clinical, scientific, or corporate, and let's advance the future of wound care together.
Contact Us